Azenta Inc
NASDAQ:AZTA

Watchlist Manager
Azenta Inc Logo
Azenta Inc
NASDAQ:AZTA
Watchlist
Price: 50.685 USD 1.31% Market Closed
Market Cap: 2.3B USD
Have any thoughts about
Azenta Inc?
Write Note

Gross Margin
Azenta Inc

40.1%
Current
43%
Average
44%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
40.1%
=
Gross Profit
263.4m
/
Revenue
656.3m

Gross Margin Across Competitors

Country US
Market Cap 2.3B USD
Gross Margin
40%
Country US
Market Cap 1.2T USD
Gross Margin
55%
Country US
Market Cap 202.3B USD
Gross Margin
41%
Country US
Market Cap 166.6B USD
Gross Margin
60%
Country KR
Market Cap 66.8T KRW
Gross Margin
49%
Country CH
Market Cap 38.4B CHF
Gross Margin
29%
Country US
Market Cap 38.8B USD
Gross Margin
55%
Country US
Market Cap 36.3B USD
Gross Margin
35%
Country US
Market Cap 27B USD
Gross Margin
59%
Country US
Market Cap 24.1B USD
Gross Margin
35%
Country CN
Market Cap 164.6B CNY
Gross Margin
40%
No Stocks Found

Azenta Inc
Glance View

Market Cap
2.3B USD
Industry
Life Sciences Tools & Services

Azenta Inc. emerged as a focused entity after the strategic divestiture of Brooks Automation's semiconductor business, carving out a niche to serve the life sciences industry with precision. The company's evolution is a testament to its strategic agility, aligning itself with the burgeoning demand for data-driven decision-making in healthcare and biotechnology. Azenta specializes in providing comprehensive solutions that revolve around sample management, genomic services, and automated storage systems. By ensuring the integrity and accessibility of biological samples and data, Azenta plays a crucial role in accelerating research and development processes. Its core operations are built upon intricate platforms that manage critical laboratory activities and genomic sequencing, enabling laboratories and research institutions to streamline their workflows and enhance productivity. Central to Azenta's business model is its recurring revenue stream derived from life science products and services, which supports labs in safeguarding and optimizing essential research materials. The company's offerings encompass robust automated systems, state-of-the-art genomic services, and logistics that ensure seamless sample management from collection to analysis. Through strategic partnerships and continuous innovation, Azenta effectively supports its clients in navigating the complexities of modern research, ultimately helping translate scientific endeavors into tangible outcomes. By continually expanding its technological capabilities and service offerings, Azenta not only fortifies its market position but also underscores its commitment to facilitating transformative advancements in life science and healthcare industries.

AZTA Intrinsic Value
34.225 USD
Overvaluation 32%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
40.1%
=
Gross Profit
263.4m
/
Revenue
656.3m
What is the Gross Margin of Azenta Inc?

Based on Azenta Inc's most recent financial statements, the company has Gross Margin of 40.1%.